10th Myanmar Obstetrical and Gynaecological Congress, in Yangon, Myanmar

Gynuity staff participated in the 10th Myanmar Obstetrical and Gynaecological Congress, in Yangon, Myanmar from February 23-24. Gynuity hosted a Symposium entitled “Frequently asked questions and Evidence-based Answers on Use of Misoprostol for Women’s Health”. The symposium was attended by approximately 200 OBGYNs from around the country. Presentations included the following:

• First-line Care for Incomplete Abortion with Misoprostol: The Way Forward for Task-shifting to Lower-level Providers: Laura Frye, Gynuity Health Projects
• First and Second Trimester Medical Abortion Protocols and Service Delivery: Overview of the Evidence: Professor Paul Blumentha, Gynuity Health Projects, Stanford University, and PSI
• Misoprostol for PPH prevention: Overview of the Evidence and Current Efforts in Nepal: Dr. Swaraj Rajbhandari, Consultant, Nepal
• Overview of Community Programs Seeking to Introduce Misoprostol for Women’s Health: Dr. Jeffrey Smith, MCHIP
• Misoprostol: A Proven Technology for Treatment of PPH - Overview of the Clinical Evidence: Laura Frye, Gynuity Health Projects
• WHO Guidelines on Use of Misoprostol: Dr. Joao Paulo Souza, WHO